Nutrients, 14 (7), 1522
Doyle-Delgado K, Chamberlain JJ, Shubrook JH, Skolnik N, Trujillo J
22 After its formation, TMAO is excreted from the liver into the bloodstream via specialized transporters
In Study 4, at Week 68, the body weight was missing for 8.4% and 7.4% of patients randomized to WEGOVY injection and placebo, respectively
From a cardiovascular perspective, the glucagon components contribution to increased energy expenditure and fat oxidation translates to greater reductions in the visceral fat deposits most strongly associated with cardiovascular disease
Cardiovascular and Metabolic Improvements Beyond weight loss, semaglutide has been shown to reduce blood pressure, improve cholesterol profiles, and decrease markers of systemic inflammation all of which contribute to a lower risk of heart disease and metabolic syndrome